|
|
||||||||
J Biol Chem, Vol. 275, Issue 16, 12061-12068, April 21, 2000
From the Ribosomal protein L5 is part of the 60 S
ribosomal subunit and localizes in both the cytoplasm and the nucleus
of eukaryotic cells, accumulating particularly in the nucleoli. L5 is
known to bind specifically to 5 S rRNA and is involved in
nucleocytoplasmic transport of this rRNA. Here, we report a detailed
analysis of the domain organization of the human ribosomal protein L5.
We show that a signal that mediates nuclear import and nucleolar localization maps to amino acids 21-37 within the 297-amino acid L5
protein. Furthermore, carboxyl-terminal residues at positions 255-297
serve as an additional nuclear/nucleolar targeting signal. Domains
involved in 5 S rRNA binding are located at both the amino terminus and
the carboxyl terminus of L5. Microinjection studies in somatic cells
demonstrate that a nuclear export signal (NES) that maps to amino acids
101-111 resides in the central region of L5. This NES is characterized
by a pronounced clustering of critical leucine residues, which creates
a peptide motif not previously observed in other leucine-rich NESs.
Finally, we present a refined model of the multidomain structure of
human ribosomal protein L5.
The biogenesis of eukaryotic ribosomes occurs at a specific
subnuclear compartment, the nucleolus, and requires the coordinated assembly of four different rRNAs and approximately 80 ribosomal proteins (1, 2). The 5.8, 18, and 28 S rRNAs are synthesized by RNA
polymerase I in the nucleolus, whereas, in contrast, 5 S rRNA is
transcribed by RNA polymerase III in the nucleoplasm. The ribosomal
proteins are encoded by mRNAs that are synthesized by RNA
polymerase II. After translation, these proteins are imported from the
cytoplasm into the nucleolus for assembly of the 40 S and 60 S
ribosomal subunits. These, in turn, are then exported to the cytoplasm.
Thus, multiple intracellular transport activities between the nucleus
and cytoplasm are required for de novo ribosome synthesis.
In eukaryotic cells, the 5 S rRNA is part of the 60 S ribosomal
subunit. In addition, a significant amount of 5 S rRNA is complexed
with various proteins to form nonribosome-associated ribonucleoprotein
particles. After transcription, 5 S rRNA is able to transiently bind
the La antigen, a 50-kDa protein that acts in the termination of
polymerase III transcripts, in the nucleus (3, 4). Furthermore, in the
nucleus, 5 S rRNA also binds either its own transcription factor IIIA
or ribosomal protein L5, forming 7 or 5 S ribonucleoprotein particles,
respectively (reviewed in Ref. 5). In particular, it has been suggested that the 5 S rRNA·L5 complex (5 S ribonucleoprotein particle) acts as
a precursor to ribosome assembly by delivering 5 S rRNA from the
nucleoplasm to the nucleolar assembly site of 60 S ribosomal subunits
(6). Studies in Xenopus oocytes have shown that 5 S rRNA can
be exported from the nucleus to the cytoplasm for subsequent accumulation at distinct cytoplasmic storage sites by either
transcription factor IIIA or L5 (7, 8). As a consequence of increased ribosomal subunit synthesis, stored 5 S rRNA must be reimported from
the cytoplasm into the oocyte nucleus. In contrast to nuclear export,
however, the nuclear import of 5 S rRNA appears to be exclusively
mediated by L5 protein (9-11). Although cytoplasmic storage sites for
5 S rRNA have not been observed in mammalian cells, the data so far
raised in Xenopus oocytes demonstrated that L5 protein is an
intracellular 5 S rRNA transport factor.
In addition to its 5 S rRNA transport activity, L5 has also been shown
to bind to other cellular proteins that participate in various
intracellular transport pathways. For example, L5 interacts with the
Mdm2 oncoprotein (12). Mdm2 is an inhibitor of the p53 tumor suppressor
gene product that, upon binding to it, promotes the degradation of p53
via the ubiquitin-dependent proteasome pathway (13, 14).
Importantly, Mdm2 has been shown to shuttle between the nucleus and
cytoplasm of mammalian cells, and Mdm2-mediated nuclear export of p53
has been suggested to lead to p53 degradation (15, 16). Furthermore, L5
has been shown to bind to eukaryotic initiation factor 5A (17), which
is a critical cellular cofactor of the Rev trans-activator
of human immunodeficiency virus type 1 (HIV-1)1 (18, 19). Rev is a
nucleocytoplasmic shuttle protein that is required for the nuclear
export of unspliced and incompletely spliced HIV-1 mRNAs (reviewed
in Ref. 20). Interestingly, competition experiments in
Xenopus oocytes have previously demonstrated that the
nuclear export pathways for Rev and 5 S rRNA share common components
(21). Taken together, these data indicate that L5 protein may play a
role in nucleocytoplasmic trafficking, in addition to its role in 5 S
rRNA transport.
The purpose of this study was to characterize in detail the regions of
ribosomal protein L5 that are required for intracellular trafficking,
subcellular localization, and 5 S rRNA interaction.
Molecular Clones--
The plasmid p3L5, expressing human L5
protein, and the plasmid pBrevM10BL-BFP have been described in detail
previously (17, 22). Wild-type and mutant L5 genes were cloned into
various expression vectors by standard methods using synthetic
double-strand oligonucleotides or polymerase chain reaction technology.
Plasmids expressing L5-GFP fusion proteins were generated by cloning
the respective L5 coding regions in the unique NheI site of
the vector pF25 (23). Accordingly, various L5 coding regions were
subcloned between the XbaI and XhoI site of the
vector pBC12/CMV/ Cell Cultures and Transfections--
HeLa cells were maintained
and transfected with calcium phosphate as described previously (23).
Localization studies in living cells were performed by transient
transfection of 2.0 × 105 HeLa cells, grown in 50-mm
glass-bottomed dishes (MatTek Co.) using phenol red-free Dulbecco's
modified Eagle's medium, with 2 µg of the various L5-GFP expression
plasmids. GFP expression in the transfected cell cultures was analyzed
at 16 h posttransfection. To determine the subcellular
localization of Purification of Recombinant Fusion Proteins and RNA Binding
Assay--
GST fusion proteins were expressed in E. coli
BL21 and purified from crude lysates by affinity chromatography on
glutathione-Sepharose 4B (Amersham Pharmacia Biotech) as described
previously (17, 24, 26). RNA gel retardation assays were performed
using an in vitro-transcribed 32P-labeled 5 S
rRNA probe, MS2 competitor RNA, and GST fusion protein as described
previously (27).
Microscopy, Immunofluorescence Studies, and
Microinjection--
Transfected cells expressing GFP fusion proteins
were analyzed either by a Zeiss LSM 410 Micro System in the confocal
mode or using a Zeiss Axiovert-135 microscope as described (23, 24). Detection of
Nuclear/nucleolar import assays were performed by comicroinjection of
Vero cells into the cytoplasm or nucleoplasm with GST-L5-GFP hybrid
proteins (1.5 mg/ml) and rabbit IgG (1.0 mg/ml) (injection control).
Cells were fixed at 45 min postinjection with paraformaldehyde, and the
injected proteins were visualized by GFP-specific and rabbit
IgG-specific fluorescence as described above. Nuclear export assays
were performed by comicroinjection of Vero cells into the nucleus with
GST-L5 proteins (1.5 mg/ml) and rabbit IgG (1.0 mg/ml) (injection
control). Cells were fixed at 30 min postinjection with
paraformaldehyde, and the injected proteins were visualized by indirect
immunofluorescence analysis as described previously (19).
Immunofluorescence analyses were performed using a Zeiss Axiovert-135
microscope. Images were recorded with a cooled MicroMax CCD camera
(Princeton Instruments) and processed using the IPLab spectrum and
Adobe Photoshop package.
Nuclear Import and Nucleolar Localization of Ribosomal Protein
L5--
It has previously been observed that the L5 protein
accumulates primarily in the nucleus and particularly in the nucleoli of mammalian cells (6). In order to define the sequences in L5 that
mediate its nuclear import and possibly nucleolar localization in more
detail, we first performed subcellular localization studies on
wild-type and mutant L5 proteins in living cells. For this, we
constructed a series of expression plasmids that contain various L5
sequences fused in frame to a gene encoding an enhanced version of the
green fluorescent protein (GFP) of Aequorea victoria (Table I). These constructs were transfected
transiently into HeLa cells and monitored for GFP expression 16 h
posttransfection. As published previously (28), expression of GFP alone
resulted in cytoplasmic and nucleoplasmic signals, clearly sparing the
nucleoli (not shown). In contrast, expression of the 297-amino acid
(aa) L5 wild-type-GFP protein resulted in nuclear accumulation of the
fusion protein with significant concentration in the nucleoli (Fig.
1A). Inspection of L5-GFP
variants revealed that regions in both the L5 amino terminus (aa 1-92)
and carboxyl terminus (aa 235-297) mediate strong nucleolar
localization (Fig. 1, B and C, respectively). Nucleolar localization was also seen when small amino-terminal (aa
23-37) or carboxyl-terminal regions (aa 255-265) of L5 were fused to
GFP, although nuclear accumulation in general appeared to be somehow
diminished (Fig. 1, D and E). Finally, the
central region of L5 protein (aa 36-254) displayed an intracellular
localization similar to that of GFP alone (Fig. 1F).
As GFP alone is equally distributed between the cytoplasmic and nuclear
compartment (28), we also tested the L5 proteins for their ability to
target an exclusively cytoplasmic protein to the cell nucleus. A series
of vectors expressing
The data presented so far measured the steady-state accumulation of
transiently expressed L5 proteins. In order to gain insight into the
kinetic of the potential nuclear/nucleolar targeting capacity of the L5
carboxyl terminus, we next employed a recently established
microinjection-based assay system (24). For this, we generated
recombinant transport substrates in which L5-derived sequences were
fused to a chimeric GST-GFP tag (Table I). These fusion proteins were
microinjected together with rabbit IgG (injection control) either into
the cytoplasm or nucleoplasm of Vero cells. After 45 min of incubation
at 37 °C, cells were fixed with paraformaldehyde, and the injected
proteins were visualized by GFP- and IgG-specific fluorescence. As
shown in Fig. 3, the L5 carboxyl terminus
(aa 255-297) directed the respective GST-GFP hybrid protein into the nucleolus (Fig. 3, A and B). In contrast,
GST-L5-265/297-GFP and GST-L5-255/265-GFP chimeras were
import-deficient and remained in the cytoplasm (Fig. 3,
C-F). When the same transport substrates were
microinjected directly into the nucleoplasm of Vero cells, strong
nucleolar accumulation was observed in case of the GST-L5-255/297-GFP protein (Fig. 4,
A-C). This accumulation was not detected when L5
aa 255-264 was deleted in GST-L5-265/297-GFP (Fig. 4,
D-F). A weak nucleolar accumulation was observed
by microinjection of the GST-L5-255/265-GFP protein (Fig. 4,
G-I).
Summarizing the data obtained in living and fixed cells, strong nuclear
import of L5 is mediated by a region located in the amino terminus of
the protein (aa 21-37). This sequence also contributes to nucleolar
localization of L5. In comparison, the L5 carboxyl terminus (aa
255-297) contains a rather weak nuclear localization signal and
sequences at aa position 255-265 contribute to nucleolar localization.
The notion that a weak NLS is located in the L5 carboxyl terminus is
also in agreement with the finding that this signal was unable to
mediate nuclear steady-state accumulation of 5 S rRNA Binding Characteristics of Wild-type and Mutant L5
Proteins--
The binding of rat L5 protein to human 5 S rRNA has been
investigated previously (29). In this work, biotinylated 5 S rRNA was
incubated with radioactive-labeled L5 protein generated by in
vitro translation in reticulocyte extracts. Protein·RNA
complexes were then precipitated using streptavidin beads and bound
proteins were analyzed by protein gel electrophoresis. When we
initially used the same experimental system to study 5 S rRNA·L5
interaction, we realized that in vitro translated L5
proteins form homodimers with the wild-type L5 that is present in
abundance in the reticulocyte lysates. In fact, subsequent
gel-filtration analysis of recombinant wild-type L5 protein also
provided independent evidence that L5 has the capacity to form protein
homodimers.2 The biological
significance of this protein-protein interaction is currently unknown.
In order to avoid the effects of indirect binding events we therefore
decided to employ RNA gel retardation analysis to assess the direct
interaction of L5 proteins to 5 S rRNA in a defined system. For this,
wild-type and selected mutant L5 proteins were expressed and purified
in the context of fusions to GST and then analyzed in combination with
an in vitro transcribed human 5 S rRNA probe (Fig.
5). The addition of increasing amounts of
GST-L5 wild-type protein to the binding reaction mixture resulted in
the appearance of a 5 S rRNA·protein complex with slower mobility in
nondenaturing gel electrophoresis (Fig. 5A). Control
experiments demonstrated that GST alone does not bind to 5 S rRNA (Fig.
5B). Furthermore, the addition of anti-L5 antibody (17) to a
preformed RNA·protein complex resulted in the detection of a
supershift-signal (Fig. 5C, lane 2 versus lane 3),
confirming that the retarded complex contains L5 protein. As expected,
addition of an unrelated antibody (
We next examined the 5 S rRNA binding-characteristics of GST-L5 mutant
proteins using this RNA gel retardation assay system. Again, titration
of GST-L5 wild-type protein to 5 S rRNA resulted in the appearance of a
retarded protein·nucleic acid complex, whereas, in contrast, no 5 S
rRNA binding was observed when a GST fusion protein containing the
internal region of L5 protein (aa 39-251) was used (Fig.
5F). The subsequent addition of the amino-terminal or
carboxyl-terminal L5 regions that contain sequences involved in nuclear
import and nucleolar localization of L5, reestablished 5 S rRNA binding
(Fig. 5G). In both cases, addition of increasing amounts of
GST-L5 mutant protein caused the subsequent appearance of two distinct
signals, which may reflect dimer-formation by L5.
Taking the binding data together, our studies suggest that two distinct
regions mediate 5 S rRNA binding. These regions are located in both the
amino terminus (aa 1-38) and the carboxyl terminus (aa 252-297) of
the L5 protein.
Nuclear Export of L5 Protein--
The export of L5 protein from
the nucleus to the cytoplasm can be visualized independent of nuclear
import, by microinjection of GST-L5 fusion protein into the nuclei of
somatic cells, followed by indirect immunofluorescence analysis (17).
We observed that the export efficiency of wild-type L5 protein was low
and varied between different batches of recombinant protein
preparations (not shown). However, when we microinjected a mutant
fusion protein, which contained the central region of L5 (aa 39-251)
but lacked the RNA binding regions of L5, efficient nuclear export was
always observed. As shown in Fig. 6, a
significant amount of the nuclear L5-39/251 protein was transported to
the cytoplasm, whereas co-microinjected rabbit IgG control protein
remained in the nucleus (Fig. 6, A and B). The
nuclear export of proteins is believed to be mediated by NESs, of which
the most common type is characterized by a typical pattern of evenly
spaced leucine residues (see below). However, this type of sequence
motif is not present within the L5 protein (17, 35). In fact, only a
single leucine-rich region exists in L5; this region is characterized
by a cluster of five leucine residues that map to amino acid positions
103, 104, 105, 109, and 110 (depicted in Fig. 8A). We
therefore microinjected GST fusion proteins, containing this L5-derived
leucine-rich cluster into the cell nucleus. As shown in Fig. 6, a short
L5 region of 11 amino acids (aa 101-111) directed a significant amount
of the heterologous GST protein from the nucleus into the cytoplasm of Vero cells (L5-NES; Fig. 6, C and D). Residual
export activity only was observed upon injection of the L5-
Taken together, these data demonstrated that the leucine-rich region,
which maps to L5 amino acid position 101-111, constitutes a NES that
is required for nucleocytoplasmic trafficking of human ribosomal
protein L5.
In the present study, we have investigated the domain organization
of ribosomal protein L5. L5 is a nucleocytoplasmic shuttle protein that
is involved in the intracellular transport of 5 S rRNA (6, 7, 10). This
transport activity requires the interaction of L5 with nuclear import
and export factors. However, the regions in L5 that mediate these
protein-protein interactions, as well as the region required for 5 S
rRNA binding, have to date been poorly defined. In fact, evidence for a
distinct domain organization in mammalian L5 originated from a previous
study in which the domain structure of the L5 protein from rat was
investigated (29). In this work, it was shown that the L5 amino
terminus (aa 1-93) contains a 5 S rRNA binding domain and that the
carboxyl terminus (aa 151-296) harbors a signal that targets L5 to the
nucleus/nucleolus.
By investigating the subcellular localization of L5 fusion proteins in
living as well as in fixed cells, we were able to map two independent
regions that serve as nuclear/nucleolar targeting signals. The region
located in the L5 amino terminus maps to amino acid residues at
position 21-37 (depicted in Fig.
8A). Fusion of a corresponding
amino acid sequence to otherwise cytoplasmic To date, no clear consensus sequence has been reached on what directs
nuclear proteins to the nucleolus. Delineation of the sequence
requirements for subcellular localization of chicken nucleolin has
revealed that the RNA binding motifs in nucleolin also cause its
accumulation in the nucleoli (41). These data suggest that nucleolin is
not transported actively into the nucleoli but rather is retained in
this specific subnuclear compartment as a result of its interaction
with rRNA. In this study, analysis of the 5 S rRNA binding phenotypes
using RNA gel retardation analyses demonstrated that the amino-terminal
and carboxyl-terminal regions, which encompass the signals required for
nuclear and nucleolar localization of L5 (aa 1-38 and 252-297), are
necessary for 5 S rRNA binding. Obviously, these regions are
characterized by a high number of basic residues that may contribute to
RNA binding. In summary, it appears that binding of L5 to 5 S rRNA
correlates with its ability to accumulate in the nucleoli. Thus,
targeting of L5 to the nucleoli seems to be achieved by the same
mechanism as seen in other nucleolar proteins, such as nucleolin
(41).
The nuclear export of proteins is mediated by NESs, the prototypic
signal of which was originally identified in the HIV-1 Rev protein (21,
42). Subsequently, structurally and functionally equivalent export
signals have been described in various proteins, including human T-cell
leukemia type I Rex (43), cAMP-dependent protein kinase
inhibitor (42), mitogen-activated protein kinase kinase (44), and the
hdm-2 oncoprotein (15) (depicted in Fig. 8B). Moreover, this
type of NES is composed of four critically spaced hydrophobic, mainly
leucine residues, which appear to be required for the interaction of
the NES with the export receptor CRM1 (36-38, 45). In particular, the
spacing of these hydrophobic (leucine) residues is considered to be a
hallmark feature for this type of leucine-rich NES. The delineation of
the NES of ribosomal protein L5 in this study, however, has revealed a
different leucine-rich export signal. Obviously, the L5 NES (aa
101-111) is composed of critical leucines arranged in two separated
clusters with no spacing between the individual leucine residues (Fig.
8B). Efficient nuclear export was observed with this signal,
particularly when nucleolar retention of L5 was abolished by removing
the protein regions that are responsible for 5 S rRNA binding and
nucleolar targeting. Moreover, mutation of these leucine residues in
the context of full-length L5-GFP demonstrated that this signal indeed affects the intracellular distribution of L5. This is in perfect agreement with the previous finding that the deletion of a short stretch of six amino acid residues in yeast ribosomal protein L1, which
is the yeast homologue of L5, caused lethality in vivo (46).
Taking our data into consideration, it is now obvious that this
deletion (L1 aa 103-108: NH2-LLIARR-COOH) removed the central part of the L1 NES, a domain that is conserved among the eukaryotic 5 S rRNA-binding proteins. Finally, leptomycin B, a drug
that has previously been shown to be an inhibitor of CRM1 (36-38)
blocked the nuclear export of the L5 NES in our experiments. These data
further support the notion that CRM1 is an export receptor for
leucine-rich NESs in general. However, it remains to be seen whether
additional factors are required for the nucleocytoplasmic translocation
of specific RNAs such as 5 S rRNA.
In summary, ribosomal protein L5 is characterized by a multidomain
structure. The delineation of the regions that are required for nuclear
import, nucleolar localization, and nuclear export provides a tool to
search for as yet unidentified L5 interaction partners. Moreover, we
expect that sequences similar to the L5 NES will soon be identified in
other proteins that traffic between the nucleus and cytoplasm of
eukaryotic cells.
We thank Barbara Kappel and Lotte Hofer for
excellent technical assistance, E. Hudson for confocal microscopy, and
Sarah L. Thomas for comments on the manuscript.
Since submission of this work a similar
study on Xenopus and rat L5 protein was published (Claußen, M., Rudt,
F., and Pieler, T. (1999) J. Biol. Chem. 274, 33951-33958.
*
This work was supported by Deutsche Forschungsgemeinschaft
Grant SFB466.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
These authors contributed equally to this work.
**
To whom correspondence should be addressed. Tel.: 49-9131-85-26182;
Fax: 49-9131-85-22101; E-mail: jmhauber@viro.med.uni- erlangen.de.
2
O. Rosorius, unpublished data.
The abbreviations used are:
HIV-1, human
immunodeficiency virus type 1;
GFP, green fluorescent protein;
GST, glutathione S-transferase;
Human Ribosomal Protein L5 Contains Defined Nuclear Localization
and Export Signals*
§,
§,
§,
,
, and
**
Institute for Clinical and Molecular
Virology, University Erlangen-Nürnberg, Schloßgarten 4, D-91054 Erlangen, Germany and the ¶ Novartis Research Institute,
Department of Immunology, Brunner Straße 59, A-1235 Vienna, Austria
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
![]()
MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
Gal (18), resulting in plasmids expressing
Gal-L5 fusion proteins. The plasmids pGEX-L5 and pGEX-Rev are
bacterial vectors that express the human L5 and HIV-1 rev
genes, respectively, fused to the carboxyl terminus of glutathione
S-transferase (GST) (17, 19). Variants of pGEX-L5 possessing
mutated L5 genes were generated by exchange of the wild-type gene for
the respective mutated gene. The vector pGEX-L5-NES expresses a short
peptide motif (L5 amino acid position 101-111) fused to GST.
pGex-L5-
1NES and pGEX-L5-
2NES express mutated versions of this
fusion protein in which the leucine residues corresponding to L5 amino
acid position 103-105 or 103-105, 109, and 110 were mutated into
alanines. Bacterial vectors expressing GST-L5-GFP fusion proteins were
generated by insertion of double-strand synthetic oligonucleotides or
polymerase chain reaction-generated L5-derived DNA fragments between
the BamHI and NheI site of pGEX-GFP (24). The
gene encoding human 5 S rRNA was isolated from a human cDNA by
polymerase chain reaction, introducing terminal HindIII and
BamHI sites. The product was digested with the respective enzymes and inserted in the vector pcDNA3. The isolated cDNA
encodes a copy of the previously published 5 S rRNA sequence (25).
Gal-L5 fusion proteins, 1.5 × 105
HeLa cells were transfected with 5 µg of the respective expression vectors. At 40 h posttransfection, cells were fixed and subjected to
Gal-specific indirect immunofluorescence analysis.
Gal expression was performed on paraformaldehyde-fixed cell cultures by indirect immunofluorescence as described previously (19).
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
Localization phenotypes of L5 proteins
Gal, or GST-GFP
reporter. Expression of the respective fusion constructs in HeLa cells
or microinjection of the GST-GFP fusion proteins into Vero cells
allowed the mapping of regions in L5 that mediate nuclear import and
nucleolar localization. Of note, GFP alone localizes in the cytoplasm
and nucleus, but not in the nucleoli of expressing cells (28). In
contrast, the
Gal reporter allows monitoring of nuclear import but
not nucleolar localization (29). NA, not applicable.

View larger version (144K):
[in a new window]
Fig. 1.
Localization of L5-GFP hybrids in living
cells. HeLa cells were transiently transfected with constructs
expressing the fusion proteins indicated and analyzed at 16 h
posttransfection by confocal laser scanning microscopy without
fixation.
Gal-L5 fusion proteins were therefore
generated and subcellular localization of the respective gene products
visualized 40 h posttransfection, using indirect
immunofluorescence microscopy on fixed HeLa cells (summarized in Table
I). As expected,
Gal localized in the cytoplasm (Fig.
2A), but was directed into the
nucleus when it was expressed as a fusion to L5 wild-type protein (Fig.
2B). Nucleolar accumulation was not observed when
Gal
served as a reporter for L5 subcellular localization. Although the
reason for this is still unknown, the observation that
Gal cannot be
used as a reporter to investigate nucleolar localization was also made
in a previous study (29). Thus, only sequences mediating nuclear
import, but not sequences required for nucleolar localization, can be
identified by this experimental approach. Inspection of the data
obtained revealed that a strong nuclear import signal resides in the
amino-terminal half of L5 (Fig. 2, C-F), apparently mapping
to residues located at amino acid position 21-35 (Fig. 2H).
In addition, fusion proteins containing the carboxyl-terminal part of
L5 (aa 150-297) also accumulated in the nucleus (Fig. 2, L
and M), indicating the presence of an additional nuclear
targeting signal. However, this nuclear accumulation was not observed
when L5 variants containing aa residues 36-297 or 255-265 were
expressed (Fig. 2, I and K).

View larger version (33K):
[in a new window]
Fig. 2.
Steady-state localization of chimeric
Gal-L5 fusion proteins. HeLa cell cultures
were transiently transfected with constructs expressing the fusion
proteins indicated. At 40 h posttransfection, cells were fixed
with paraformaldehyde, and the subcellular localization of
Gal
(A) or
Gal-L5 fusion proteins (B-M) was
determined by indirect immunofluorescence analysis using a
Gal-specific antibody.

View larger version (133K):
[in a new window]
Fig. 3.
Nuclear import of GST-L5-GFP hybrid
proteins. Vero cells were comicroinjected in the cytoplasm with
the indicated fusion proteins (B, D, and
F) and rabbit IgG (injection control, IgG; A,
C, and E). Cells were incubated for 45 min,
fixed, and analyzed for GFP- and rabbit IgG-specific localization by
fluorescence microscopy. The L5 carboxyl terminus (aa 255-297)
mediated nuclear import and nucleolar accumulation of the GST-GFP
reporter (A and B).

View larger version (98K):
[in a new window]
Fig. 4.
Nucleolar import of GST-L5-GFP hybrid
proteins. Vero cells were comicroinjected in the nucleoplasm with
the indicated fusion proteins (B, E, and
H) and rabbit IgG (injection control, IgG; A,
D, and G). Cells were incubated for 45 min,
fixed, and analyzed for GFP- and rabbit IgG-specific localization by
fluorescence microscopy. Corresponding phase contrast images are shown
in C, F, and I. The L5 carboxyl
terminus (aa 255-297) mediates strong nucleolar accumulation of the
GST-GFP reporter (A-C).
Gal-L5 fusion proteins
that also contained the L5 NES (aa 101-111, see below; Fig.
2I). In contrast,
Gal-L5 fusion proteins that carry the
strong amino-terminal NLS were easily detectable in the nucleus, even
when the NES was present (Fig. 2, C and D).
-
Gal) did not affect the 5 S
rRNA·L5 complex (Fig. 5C, lane 4). In order to validate
the 5 S rRNA-based gel retardation assay system further, we next
investigated the binding characteristics of the HIV-1 Rev
trans-activator protein. As shown in a previous study by
time-resolved fluorescence spectroscopy, Rev appears to interact with 5 S rRNA in a similar manner to its interaction with its homologous viral
Rev response element RNA target (30). In close agreement with these
data, GST-Rev protein clearly bound 5 S rRNA in our gel retardation
assay system (Fig. 5D) and, moreover, preformed complexes
were supershifted using a Rev-specific antibody (31) (Fig. 5D,
lane 4). Addition of increasing amounts of Rev to the binding
reaction mixture resulted in the successive appearance of 5 S
rRNA·protein complexes with slower mobilities (Fig. 5E, lanes
3-6). The clear resolution of the retarded 5 S rRNA probe in
multiple distinct bands has been shown to be due to the cooperative binding of multiple Rev molecules to a single RNA target (26, 32).
Interestingly, L5 wild-type protein competed efficiently for 5 S rRNA
binding when the protein was added to preestablished 5 S rRNA·Rev
complexes (Fig. 5E, lane 7), suggesting that L5 binds with
higher affinity and both proteins target the same binding site on 5 S
rRNA. Whether or not this is indeed the case will be the subject of
future studies in which the affinities of both proteins for 5 S rRNA
will be determined in detail. The affinity of HIV-1 Rev for 5 S rRNA,
however, may be the reason why this viral regulatory protein displays a
pronounced nucleolar steady-state accumulation in expressing cells (33,
34).

View larger version (47K):
[in a new window]
Fig. 5.
In vitro 5 S rRNA binding analysis
of wild-type and mutant GST-L5 proteins. A constant level of a
32P-labeled human 5 S rRNA probe was incubated with
increasing amounts (1-4 µg, lanes 2-4) of GST-L5
wild-type (A) or GST protein (B) and then
subjected to RNA gel mobility shift analysis. The location of the free
(unbound) 5 S rRNA probe is shown in lane 1 and indicated to
the left of each panel. Protein·nucleic acid complexes are
indicated by an asterisk to the right of each
panel. C, analysis of preformed 5 S rRNA·L5 complexes
(lanes 2-4; 2 µg of GST-L5) by addition of antibodies
directed against L5 (
-L5; lane 3) or
Gal
(
-
Gal; lane 4). D, direct interaction of
HIV-1 Rev trans-activator protein with 5 S rRNA.
Protein·nucleic acid complexes are recognized by anti-Rev antibodies
(
-Rev; lane 4). E, binding competition
experiments using Rev and L5 proteins. The 5 S rRNA probe was incubated
with increasing amounts (500 ng to 4 µg, lanes 3-6; 4 µg, lane 7) of GST-Rev protein. GST-L5 (4 µg) was added
to unbound 5 S rRNA (lane 2) or to preformed Rev-specific
complexes (lane 7). F and G, analysis
of L5 deletion mutant proteins (indicated at the bottom of
each panel) as described above. The position of unbound 5 S rRNA is
visualized in lanes 1 and 5 of each gel.
WT, wild-type.
1NES
fusion protein, in which the leucine residues at L5 amino acid position
103-105 were mutated into alanines (Fig. 6, E and
F). Clearly, nuclear export was completely abrogated when
all leucine residues present in this L5-derived region were
simultaneously substituted by alanines (L5-
2NES; Fig. 6,
G and H). Moreover, when the cell cultures were
supplemented 2 h prior to microinjection with leptomycin B, which
has been previously shown to be an inhibitor of the general export
receptor CRM1 (36-39), the injected wild-type protein (L5-NES) remained in the nucleus (Fig. 6, I and K). In
order to analyze the activity of this leucine-rich sequence in the
context of full-length L5 we also introduced the respective leucine to
alanine mutations at aa positions 103-105, 109, and 110 in our L5-GFP
expression construct. As shown before (Fig. 1A), transient
transfection of HeLa cells with the L5-GFP vector resulted in
cytoplasmic and nuclear localization of the expressed fusion protein
(Fig. 7A). Coexpression of the
RevM10-BFP hybrid protein, which has been previously reported to be an
exclusively nucleolar protein (22), also demonstrated in this
experiment that the L5-GFP wild-type protein indeed accumulates at the
nucleoli (Fig. 7B). In contrast, however, mutation of the
potential L5 NES sequence in the L5-
2NES-GFP hybrid protein resulted
in an exlusively nuclear/nucleolar fusion protein (Fig. 7C).
The complete absence of any cytoplasmic GFP-signal indicated a nuclear
export defect in the respective protein due to the mutational
inactivation of an essential NES sequence.

View larger version (33K):
[in a new window]
Fig. 6.
Nuclear export of human ribosomal protein L5
in somatic cells. Vero cells were comicroinjected into the nucleus
with the indicated GST-L5 proteins and rabbit IgG (IgG, injection
control). Cells were incubated for 30 min, fixed, and analyzed for GST-
and rabbit IgG-specific localization by double-label indirect
immunofluorescence microscopy. Nuclear export is inhibited when
critical leucine residues in the L5 NES (aa 101-111) are mutated into
alanines (
1NES: Leu103-Leu105 (E
and F);
2NES: Leu103-Leu105,
Leu109, Leu110 (G and H))
or when microinjection and cell culture was carried out in presence of
5 nM leptomycin B (LMB) (I and
K).

View larger version (8K):
[in a new window]
Fig. 7.
Mutation of the NES affects the intracellular
distribution of human ribosomal protein L5. HeLa cells were
transiently cotransfected with vectors expressing L5-GFP and
RevM10BL-BFP and analyzed at 16 h posttransfection by fluorescence
microscopy without fixation (A and B). The
wild-type L5-GFP protein localizes in the cytoplasm, nucleus, and
nucleolus (A). RevM10BL-BFP, which is a HIV-1 Rev mutant
that is characterized by nucleolar localization (22), was used to label
the nucleoli in this experiment (B). Introduction of the
2NES mutation in L5-GFP (leucine to alanine mutation of the L5 amino
acid residues at positions 103-105, 109, and 110) resulted in
exclusively nuclear/nucleolar localization (C), indicating
that nuclear export is abrogated in this mutant protein.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
Gal resulted in nuclear
accumulation of the respective fusion protein. Because the
Gal
reporter protein is not suitable to investigate L5 signals that confer
nucleolar localization (29), we also fused this L5 sequence to GFP.
This resulted in nucleolar accumulation of the respective L5-GFP fusion
protein, whereas, in contrast, no nucleolar localization was detected
when wild-type GFP was expressed (28). The combined data indicated that
this amino-terminal region in L5 serves as both a strong nuclear
localization and nucleolar targeting signal. A second region that is
involved in directing L5 to specific subcellular compartments is
located in the protein carboxyl terminus and maps to amino acid
position 255-265 (Fig. 8A). As with the amino-terminal
signal, this region mediates the nucleolar localization of GFP. In
contrast, this signal failed to target the ~116-kDa
Gal protein to
the nucleus. Fusion of the carboxyl-terminal half of L5 (aa 150-297)
to
Gal, however, resulted in nuclear steady-state accumulation of
this fusion protein. Subsequently, the microinjection of GST-GFP fusion proteins into the cytoplasm or nucleoplasm of Vero cells revealed that
the complete L5 carboxyl terminus (aa 255-297) is able to mediate
nuclear import as well as nucleolar accumulation. However, the kinetic
with which the respective GST-L5-GFP fusion protein translocated from
the cytoplasm into the nucleus was slow when compared with the kinetic
of the NLS found within the SV40 large T-antigen in this type of
experiment (data not shown). In fact, significant nuclear import of
cytoplasmic GST-L5-255/297-GFP hybrid protein was observed ~45 min
postinjection, whereas, in contrast, the translocation of a similar
GST-SV40 NLS-GFP construct was complete after ~10 min. Thus, the L5
carboxyl terminus (aa 255-297) exerts weak nuclear import activity
when compared with a classical NLS. Moreover, the sequence located
between L5 aa positions 255 and 265 appears to be required, although
not sufficient, to direct a heterologous protein into the nucleus. Note
that the amino acid composition of this L5 region resembles loosely the
NLS found within the SV40 large T-antigen. This prototypic NLS is
characterized by a short peptide motif highly enriched with positively
charged amino acids (40). In contrast, the NLS located in the L5 amino terminus (aa 21-37) resembles a bipartite NLS of the type originally identified in nucleoplasmin. This type of signal is defined by two
basic peptide regions that are separated by a spacer region of ~10
amino acid residues (40). With respect to nuclear import it is also
important to note that the L5 protein appears to form homodimers.
Because the regions responsible for dimerization are not known, we
cannot rule out the possibility that nuclear import of some reporter
constructs may have occurred due to dimerization of the respective L5
fusion proteins with endogenous wild-type L5 protein.

View larger version (29K):
[in a new window]
Fig. 8.
Domain structure of human ribosomal protein
L5. A, the distinct functional regions located within
the 297-aa L5 protein are indicated by boxes. Interaction of
L5 with 5 S rRNA is mediated by the L5 amino and carboxyl termini (aa
1-38 and 252-297; gray boxes). A sequence that mediates
nuclear import and nucleolar localization of L5 maps to amino acid
residues 21-37 (hatched box; NLS). An additional
region that is able to mediate nuclear/nucleolar localization is
located in the L5 carboxyl terminus (aa 255-297). A carboxyl-terminal
region rich in basic amino acid residues mediates nucleolar targeting
(aa 255-265; cross-hatched box). The domain that serves as
a NES is located in the central region of L5 (aa 101-111; filled
box). B, comparison of the L5 NES defined in this work
with known NESs found in other viral and cellular proteins (see text
for details). Numbers indicate the position of the amino
acids within the proteins. Critical hydrophobic residues (primarily
leucines) are shown in boldface.
![]()
ACKNOWLEDGEMENTS
![]()
Note Added in Proof
![]()
FOOTNOTES
Current address: Axxima Pharmaceuticals AG, Am Klopferspitz
19, D-82152 Martinsried, Germany
![]()
ABBREVIATIONS
Gal,
-galactosidase;
NLS, nuclear localization signal;
NES, nuclear export signal;
aa, amino acid(s).
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
1.
Warner, J. R.
(1990)
Curr. Opin. Cell Biol.
2,
521-527[CrossRef][Medline]
[Order article via Infotrieve]
2.
Sollner Webb, B.,
and Mougey, E. B.
(1991)
Trends. Biochem. Sci.
16,
58-62[CrossRef][Medline]
[Order article via Infotrieve]
3.
Rinke, J.,
and Steitz, J. A.
(1982)
Cell
29,
149-159[CrossRef][Medline]
[Order article via Infotrieve]
4.
Gottlieb, E.,
and Steitz, J. A.
(1989)
EMBO J.
8,
851-861[Medline]
[Order article via Infotrieve]
5.
Pieler, T.,
and Rudt, F.
(1997)
Semin. Cell Dev. Biol.
8,
79-82[CrossRef][Medline]
[Order article via Infotrieve]
6.
Steitz, J. A.,
Berg, C.,
Hendrick, J. P.,
La Branche-Chabot, H.,
Metspalu, A.,
Rinke, J.,
and Yario, T.
(1988)
J. Cell Biol.
106,
545-556 7.
Guddat, U.,
Bakken, A. H.,
and Pieler, T.
(1990)
Cell
60,
619-628[CrossRef][Medline]
[Order article via Infotrieve]
8.
Allison, L. A.,
North, M. T.,
and Neville, L. A.
(1995)
Dev. Biol.
168,
284-295[CrossRef][Medline]
[Order article via Infotrieve]
9.
Allison, L. A.,
Romaniuk, P. J.,
and Bakken, A. H.
(1991)
Dev. Biol.
144,
129-144[CrossRef][Medline]
[Order article via Infotrieve]
10.
Rudt, F.,
and Pieler, T.
(1996)
EMBO J.
15,
1383-1391[Medline]
[Order article via Infotrieve]
11.
Murdoch, K. J.,
and Allison, L. A.
(1996)
Exp. Cell Res.
227,
332-343[CrossRef][Medline]
[Order article via Infotrieve]
12.
Marechal, V.,
Elenbaas, B.,
Piette, J.,
Nicolas, J.-C.,
and Levine, A. J.
(1994)
Mol. Cell. Biol.
14,
7414-7420 13.
Haupt, Y.,
Maya, R.,
Kazaz, A.,
and Oren, M.
(1997)
Nature
387,
296-299[CrossRef][Medline]
[Order article via Infotrieve]
14.
Kubbutat, M. H.,
Jones, S. N.,
and Vousden, K. H.
(1997)
Nature
387,
299-303[CrossRef][Medline]
[Order article via Infotrieve]
15.
Roth, J.,
Dobbelstein, M.,
Freedman, D. A.,
Shenk, T.,
and Levine, A. J.
(1998)
EMBO J.
17,
554-564[CrossRef][Medline]
[Order article via Infotrieve]
16.
Freedman, D. A.,
and Levine, A. J.
(1998)
Mol. Cell. Biol.
18,
7288-7293 17.
Schatz, O.,
Oft, M.,
Dascher, C.,
Schebesta, M.,
Rosorius, O.,
Jaksche, H.,
Dobrovnik, M.,
Bevec, D.,
and Hauber, J.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
1607-1612 18.
Ruhl, M.,
Himmelspach, M.,
Bahr, G. M.,
Hammerschmid, F.,
Jaksche, H.,
Wolff, B.,
Aschauer, H.,
Farrington, G. K.,
Probst, H.,
Bevec, D.,
and Hauber, J.
(1993)
J. Cell Biol.
123,
1309-1320 19.
Bevec, D.,
Jaksche, H.,
Oft, M.,
Wöhl, T.,
Himmelspach, M.,
Pacher, A.,
Schebesta, M.,
Koettnitz, K.,
Dobrovnik, M.,
Csonga, R.,
Lottspeich, F.,
and Hauber, J.
(1996)
Science
271,
1858-1860[Abstract]
20.
Pollard, V. W.,
and Malim, M. H.
(1998)
Annu. Rev. Microbiol.
52,
491-532[CrossRef][Medline]
[Order article via Infotrieve]
21.
Fischer, U.,
Huber, J.,
Boelens, W. C.,
Mattaj, I. W.,
and Lührmann, R.
(1995)
Cell
82,
475-483[CrossRef][Medline]
[Order article via Infotrieve]
22.
Stauber, R. H.,
Afonina, E.,
Gulnik, S.,
Erickson, J.,
and Pavlakis, G. N.
(1998)
Virology
251,
38-48[CrossRef][Medline]
[Order article via Infotrieve]
23.
Stauber, R. H.,
Horie, K.,
Carney, P.,
Hudson, E. A.,
Tarasova, N. I.,
Gaitanaris, G. A.,
and Pavlakis, G. N.
(1998)
BioTechniques
24,
462-471[Medline]
[Order article via Infotrieve]
24.
Rosorius, O.,
Heger, P.,
Stelz, G.,
Hirschmann, N.,
Hauber, J.,
and Stauber, R. H.
(1999)
BioTechniques
27,
350-355[Medline]
[Order article via Infotrieve]
25.
Forget, B. G.,
and Weissman, S. M.
(1969)
J. Biol. Chem.
244,
3148-3165 26.
Thomas, S. L.,
Oft, M.,
Jaksche, H.,
Casari, G.,
Heger, P.,
Dobrovnik, M.,
Bevec, D.,
and Hauber, J.
(1998)
J. Virol.
72,
2935-2944 27.
Daly, T. J.,
Doten, R. C.,
Rennert, P.,
Auer, M.,
Jaksche, H.,
Donner, A.,
Fisk, G.,
and Rusche, J. R.
(1993)
Biochemistry
32,
10497-10505[CrossRef][Medline]
[Order article via Infotrieve]
28.
Stauber, R.,
Gaitanaris, G. A.,
and Pavlakis, G. N.
(1995)
Virology
213,
439-449[CrossRef][Medline]
[Order article via Infotrieve]
29.
Michael, W. M.,
and Dreyfuss, G.
(1996)
J. Biol. Chem.
271,
11571-11574 30.
Lam, W. C.,
Seifert, J. M.,
Amberger, F.,
Graf, C.,
Auer, M.,
and Millar, D. P.
(1998)
Biochemistry
37,
1800-1809[CrossRef][Medline]
[Order article via Infotrieve]
31.
Hammerschmid, M.,
Palmeri, D.,
Ruhl, M.,
Jaksche, H.,
Weichselbraun, I.,
Böhnlein, E.,
Malim, M. H.,
and Hauber, J.
(1994)
J. Virol.
68,
7329-7335 32.
Malim, M. H.,
and Cullen, B. R.
(1991)
Cell
65,
241-248[CrossRef][Medline]
[Order article via Infotrieve]
33.
Cochrane, A. W.,
Perkins, A.,
and Rosen, C. A.
(1990)
J. Virol.
64,
881-885 34.
Malim, M. H.,
Böhnlein, S.,
Hauber, J.,
and Cullen, B. R.
(1989)
Cell
58,
205-214[CrossRef][Medline]
[Order article via Infotrieve]
35.
Frigerio, J.-M.,
Dagorn, J.-C.,
and Iovanna, J. L.
(1995)
Biochim. Biophys. Acta
1262,
64-68[Medline]
[Order article via Infotrieve]
36.
Fornerod, M.,
Ohno, M.,
Yoshida, M.,
and Mattaj, I. W.
(1997)
Cell
90,
1051-1060[CrossRef][Medline]
[Order article via Infotrieve]
37.
Fukuda, M.,
Asano, S.,
Nakamura, T.,
Adachi, M.,
Yoshida, M.,
Yanagida, M.,
and Nishida, E.
(1997)
Nature
390,
308-311[CrossRef][Medline]
[Order article via Infotrieve]
38.
Ossareh-Nazari, B.,
Bachelerie, F.,
and Dargemont, C.
(1997)
Science
278,
141-144 39.
Kudo, N.,
Matsumori, N.,
Taoka, H.,
Fujiwara, D.,
Schreiner, E. P.,
Wolff, B.,
Yoshida, M.,
and Horinouchi, S.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
9112-9117 40.
Dingwall, C.,
and Laskey, R. A.
(1991)
Trends. Biochem. Sci.
16,
478-481[CrossRef][Medline]
[Order article via Infotrieve]
41.
Schmidt Zachmann, M. S.,
and Nigg, E. A.
(1993)
J. Cell Sci.
105,
799-806[Abstract]
42.
Wen, W.,
Meinkoth, J. L.,
Tsien, R. Y.,
and Taylor, S. S.
(1995)
Cell
82,
463-473[CrossRef][Medline]
[Order article via Infotrieve]
43.
Palmeri, D.,
and Malim, M. H.
(1996)
J. Virol.
70,
6442-6445[Abstract]
44.
Fukuda, M.,
Gotoh, I.,
Gotoh, Y.,
and Nishida, E.
(1996)
J. Biol. Chem.
271,
20024-20028 45.
Stade, K.,
Ford, C. S.,
Guthrie, C.,
and Weis, K.
(1997)
Cell
90,
1041-1050[CrossRef][Medline]
[Order article via Infotrieve]
46.
Deshmukh, M.,
Stark, J.,
Yeh, L.-C. C.,
Lee, J. C.,
and Woolford, J. L., Jr.
(1995)
J. Biol. Chem.
270,
30148-30156
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
M. S. Lindstrom and Y. Zhang Ribosomal Protein S9 Is a Novel B23/NPM-binding Protein Required for Normal Cell Proliferation J. Biol. Chem., June 6, 2008; 283(23): 15568 - 15576. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kundu-Michalik, M.-A. Bisotti, E. Lipsius, A. Bauche, A. Kruppa, T. Klokow, G. Kammler, and J. Kruppa Nucleolar Binding Sequences of the Ribosomal Protein S6e Family Reside in Evolutionary Highly Conserved Peptide Clusters Mol. Biol. Evol., March 1, 2008; 25(3): 580 - 590. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Malygin, N. M. Parakhnevitch, A. V. Ivanov, I. C. Eperon, and G. G. Karpova Human ribosomal protein S13 regulates expression of its own gene at the splicing step by a feedback mechanism Nucleic Acids Res., October 8, 2007; 35(19): 6414 - 6423. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Zhang, R. B. Hamanaka, E. Bobrovnikova-Marjon, J. D. Gordan, M.-S. Dai, H. Lu, M. C. Simon, and J. A. Diehl Ribosomal Stress Couples the Unfolded Protein Response to p53-dependent Cell Cycle Arrest J. Biol. Chem., October 6, 2006; 281(40): 30036 - 30045. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Yu, L. B. Maggi Jr., S. N. Brady, A. J. Apicelli, M.-S. Dai, H. Lu, and J. D. Weber Nucleophosmin Is Essential for Ribosomal Protein L5 Nuclear Export Mol. Cell. Biol., May 15, 2006; 26(10): 3798 - 3809. [Abstract] [Full Text] [PDF] |
||||